For example, PPARγ activation results in anti-inflammatory and anabolic actions; hence, PPARγ agonists like rosiglitazone have been used in the management of type II diabetes, a disease caused by widespread resistance to insulin actions [62,63]. The gene discussed is INS; the disease is type 2 diabetes mellitus.